Early Phase Clinical Trial Development
MedSource has participated in the early phases of development of novel therapeutics utilizing a variety of complex design clinical trials across the spectrum of the most challenging disease states. Over 75 percent of the studies have been either in Phase I or Phase II. The chart below illustrates the breadth of our experience in "healthy normal" studies as well as other early phase studies.
All Studies by Phase